MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types
MAX dimerization (MXD) protein 3 (MXD3) is a member of the MXD family of basic-helix-loop-helix-leucine-zipper (bHLHZ) transcription factors that plays pivotal roles in cell cycle progression and cell proliferation. However, there is insufficient scientific evidence on the pathogenic roles of MXD3 i...
Main Authors: | Szu-Yuan Wu, Kuan-Chou Lin, Bashir Lawal, Alexander T.H Wu, Ching-Zong Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037021003780 |
Similar Items
-
MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
by: Xiaoyu Zhang, et al.
Published: (2021-11-01) -
Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
by: Xiaoyu Zhang, et al.
Published: (2021-12-01) -
Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma
by: Tin Ngo, et al.
Published: (2019-02-01) -
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
by: Lirui Dai, et al.
Published: (2022-05-01) -
The role of TGR5 as an onco-immunological biomarker in tumor staging and prognosis by encompassing the tumor microenvironment
by: Zhiyuan Guan, et al.
Published: (2022-10-01)